Cancer involves abnormal cells growing uncontrollably, invading nearby tissues, and spreading to other parts of the body through metastasis.
Send us all your questions or requests, and our expert team will assist you.
Surgery is the primary and most effective treatment for thyroid cancer. The extent of surgery is a subject of nuanced clinical decision-making. For small, low-risk papillary carcinomas (typically between 1 and 4 centimeters) confined to one side of the gland, a Thyroid Lobectomy (or hemithyroidectomy) is often sufficient. This involves removing only the lobe containing the cancer and the isthmus. The advantage is that the remaining lobe may produce enough hormone to avoid the need for lifelong medication, and the risk to nerves and parathyroid glands is halved.
For larger tumors (>4 cm), bilateral disease, or evidence of extrathyroidal spread, a Total Thyroidectomy is performed. This removes the entire gland. Total thyroidectomy facilitates the use of radioactive iodine treatment post-surgery. It makes monitoring thyroglobulin levels a more sensitive cancer marker (since no normal tissue remains to produce it).
The choice involves a trade-off: Lobectomy offers a better quality of life (less medication dependence) and lower surgical risk, while Total Thyroidectomy offers easier long-term surveillance and the option for systemic radioactive iodine therapy. Guidelines have shifted towards lobectomy for lower-risk cases to prevent overtreatment.
Thyroid cancer, particularly the papillary type, frequently spreads to the lymph nodes in the neck. Therefore, the surgery often includes a neck dissection. A Central Neck Dissection removes the nodes in the compartment immediately surrounding the thyroid (Level VI). This is done therapeutically if nodes are obviously involved, and sometimes prophylactically (preventatively) in high-risk cases, although prophylactic dissection is controversial due to the increased risk of hypoparathyroidism.
If the cancer has spread to the side of the neck, a Lateral Neck Dissection (Levels II-V) is performed. This is a more extensive procedure that involves removing fatty tissue and lymph nodes along the jugular vein and carotid artery. Importantly, this is a “functional” dissection, meaning the surgeon carefully preserves the muscles, nerves, and major blood vessels; it is not the disfiguring radical dissection of the past.
The goal is to remove all macroscopic disease. Unlike some other cancers, microscopic nodal disease in thyroid cancer often does not affect survival significantly in younger patients, so surgeons balance the thoroughness of node removal with the preservation of vital neck structures.
Radioactive Iodine (I-131) therapy is a unique systemic treatment that exploits the thyroid’s physiology. Since thyroid cells (both normal and differentiated cancerous ones) are the only cells in the body that avidly absorb iodine, administering radioactive iodine acts as a “magic bullet.” The patient swallows a capsule or liquid containing I-131. The radiation travels through the bloodstream, is absorbed by any remaining thyroid tissue or cancer cells, and destroys them from the inside via beta radiation.
RAI is used for three purposes:
Preparation is key. Patients must have high TSH levels (either by withdrawing hormone medication or injection of Recombinant TSH) and follow a low-iodine diet to make the cancer cells “hungry” for the radioactive dose. Current trends favor using lower doses of RAI to minimize long-term side effects like dry mouth or salivary gland damage.
After initial treatment, the management of differentiated thyroid cancer relies on hormonal manipulation. TSH (Thyroid Stimulating Hormone) promotes the growth of thyroid cells. Therefore, keeping TSH levels low reduces the stimulus for any remaining cancer cells to grow. This is achieved by giving supra-physiological doses of Levothyroxine (thyroid hormone replacement).
The degree of suppression is risk-stratified. For high-risk patients, TSH is kept completely suppressed (<0.1 mU/L). For intermediate-risk patients, it is kept just below normal. For low-risk patients who are considered cured, TSH is allowed to be in the low-normal range.
Long-term TSH suppression is not without side effects. It creates a state of subclinical hyperthyroidism, which can affect bone density (leading to osteoporosis, especially in postmenopausal women) and heart rhythm (increasing the risk of atrial fibrillation). Therefore, the intensity of suppression is often relaxed over time if the patient remains disease-free.
A small percentage of patients develop “Radioactive Iodine Refractory” (RAI-R) disease. This occurs when cancer cells lose the ability to take up iodine (dedifferentiation), rendering RAI therapy ineffective. Historically, options were limited, but the landscape has changed with the advent of Tyrosine Kinase Inhibitors (TKIs).
Drugs like Lenvatinib and Sorafenib are multi-kinase inhibitors that block blood vessel growth (angiogenesis) and tumor cell signaling pathways. They do not cure the disease but can stabilize it for years. For patients with specific mutations, more targeted drugs are available (e.g., Selpercatinib for RET-mutated cancers, or Dabrafenib/Trametinib for BRAF-mutated anaplastic cancer).
External Beam Radiation Therapy (EBRT) is rarely used but may be employed for tumors invading the trachea or esophagus that cannot be surgically removed. Chemotherapy is generally ineffective for differentiated thyroid cancer but is used for Anaplastic Carcinoma, often combined with radiation.
Send us all your questions or requests, and our expert team will assist you.
The Recurrent Laryngeal Nerve, which controls your voice, runs right next to the thyroid. There is a small risk (about 1-2%) of temporary or permanent damage to this nerve during surgery. If damaged, you may have a hoarse or breathy voice. Surgeons often use nerve-monitoring technology during surgery to help identify and protect the nerve.
Yes. Because your body will emit radiation for a few days, you need to protect others from it. You will typically need to sleep alone, avoid close contact with children and pregnant women, and use separate bathroom facilities for a period ranging from 3 to 7 days, depending on the dose you received.
Suppose you have a total thyroidectomy, yes. You cannot survive without thyroid hormone. You will take a daily Levothyroxine pill. If you have a lobectomy (half removed), there is about a 70-80% chance your remaining half will make enough hormone, and you might not need medication.
For about two weeks before RAI treatment, you must avoid foods high in iodine. This includes iodized salt, dairy products, seafood, egg yolks, and red dye #3. This depletes your body’s iodine stores so that when the radioactive iodine is given, the thyroid cells absorb it greedily.
Yes. While the prognosis is excellent, thyroid cancer tends to recur late, sometimes 10 or 20 years later, usually in the lymph nodes of the neck. This is why lifelong annual surveillance with blood tests and ultrasound is generally recommended.
We often see patients with hypothyroidism, a condition where the thyroid gland doesn’t make enough thyroid hormones. The ICD-10 code E03.9 is for “hypothyroidism, unspecified.”
Radioactive iodine (RAI) is a common treatment for Graves’ disease and thyroid cancer. Studies show it doesn’t shorten life for most patients. It might even
Getting the thyroid gland checked right is key to good health. MRI and ultrasound help a lot in checking how well the thyroid is working.
The thyroid gland is a key part of our body, found in the neck. It helps control how our body grows and works. At Liv
At Liv Hospital, we know how important an accurate diagnosis is for your health. A CT scan of the thyroid gland is key. It helps
Understanding Thyroid Gland X-Ray and Ultrasound Knowing the normal size of the thyroid gland is key to detecting issues early. At Liv Hospital, we use
Leave your phone number and our medical team will call you back to discuss your healthcare needs and answer all your questions.
Your Comparison List (you must select at least 2 packages)
